| تعداد نشریات | 283 |
| تعداد نشریات سازمان | 81 |
| تعداد شماره‌ها | 2,766 |
| تعداد مقالات | 31,497 |
| تعداد مشاهده مقاله | 39,698,886 |
| تعداد دریافت فایل اصل مقاله | 17,254,010 |
Investigating of the side effects of covid-19 vaccines in Southern Iran: a cross-sectional study | ||
| Archives of Razi Institute | ||
| مقاله 16، دوره 79، شماره 1، فروردین و اردیبهشت 2024، صفحه 144-153 اصل مقاله (475.38 K) | ||
| نوع مقاله: Original Articles | ||
| شناسه دیجیتال (DOI): 10.32592/ARI.2024.79.1.144 | ||
| نویسندگان | ||
| Shobeir Rostami Abusaeedi1؛ Ali Asghar Kheirkhah Vakilabad1؛ Ehsan Movahed* 2؛ Moradali Zareipour3؛ Vahid Mashayekhi4؛ Shohreh Shafiei5؛ Yasin Sohrani6؛ Hossein Rafeie7؛ Fereshte Gheyabi8 | ||
| 1School of Medicine, Imam Khomeini Hospital, Jiroft University of Medical Sciences | ||
| 2Department of Health, Jiroft University of Medical University, Jiroft, Iran | ||
| 3Department of Public Health, School of Health, Khoy University of Medical Sciences, Khoy, Iran | ||
| 4Jiroft University of Medical University, Jiroft, Iran | ||
| 5Clinical Research Development Center of Imam Khomeini Hospital, Jiroft University of Medical Sciences, Jiroft, Iran | ||
| 6Clinical Research Development Unit, Imam Khomeini Hospital, Jiroft University of Medical Sciences, Jiroft, Iran | ||
| 7Postgraduate student of epidemiology،Clinical Research Development unit of Imam Khomeini Hospital, Jiroft University of Medical Sciences, Jiroft , Iran | ||
| 8Msc in a health education, Jiroft University of Medical Sciences, Jiroft, Iran | ||
| چکیده | ||
| The Covid-19 disease is a newly emerging disease, and the covid-19 vaccine is one of the necessities to prevent this disease. The present study aimed to Investigate the side effects of covid-19 vaccines in southern Iran. We used convenience sampling to conduct this cross-sectional study on 647 people living in cities under the coverage in southern Iran, Kerman. The data collection tool included a researcher-maid questionnaire of vaccine symptoms and signs. The results were analyzed by SPSS software version 24 and ANOVA, and chi-square tests. The mean age of the participants was 40.19±15.20. The results indicated that 431 people (66.6%) reported post-vaccination side effects, with 18.23% of them having severe side effects. We noticed the most severe side effects in AstraZeneca, Sinopharm, Sputnik, and Bharat. Fever, headache, and pain at the injection site were the most common side effects after vaccination respectively, which had a statistically significant relationship with all types of vaccines (P=0.001). The side effects differed in the types of vaccines and most of the vaccines had mild to moderate side effects. People with B blood type showed the most severe side effects while those with AB showed the lowest rate of side effects. Therefore, the injection of the AstraZeneca vaccine in blood group B should be done with more caution. And it is recommended more attention should be paid to blood groups B and A in the injection of Covid-19 vaccines. also, health officials and the government should plan appropriate educational strategies to increase public knowledge and the importance of vaccines in eradicating viral infections | ||
| کلیدواژه‌ها | ||
| Vaccines؛ Side effects؛ COVID-19؛ Iran | ||
| مراجع | ||
|
References 1. Jung F, Krieger V, Hufert F, Küpper J-H. Herd immunity or suppression strategy to combat COVID-19. Clinical hemorheology and microcirculation. 2020;75(1):13-7. 2. Sharma O, Sultan AA, Ding H, Triggle CR. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19. Frontiers in immunology. 2020;11:585354. 3. Cohen MS, Corey L. Combination prevention for COVID-19. American Association for the Advancement of Science; 2020. p. 551-. 4. Steele AD, Patel M, Parashar UD, Victor JC, Aguado T, Neuzil KM. Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a World Health Organization–sponsored consultation. The Journal of infectious diseases. 2009;200(Supplement_1):S63-S9. 5. Gee J, Marquez P, Su J, Calvert GM, Liu R, Myers T, et al. The first month of COVID-19 vaccine safety monitoring— United States, December 14, 2020–January 13, 2021. Morbidity and mortality weekly report. 2021;70(8):283. 6. Soiza RL, Scicluna C, Thomson EC. Efficacy and safety of COVID-19 vaccines in older people. Age and aging. 2021;50(2):279-83. 7. Anderson PO. Maternal vaccination and breastfeeding. Breastfeeding Medicine. 2019;14(4):215-7. 8. Hughes BL, Swamy G, Eckert LON, Gyamq‐Bannerman C, Turrentine M. Vaccinating pregnant and lactating patients against COVID‐19. The American College of Obstetricians and Gynecologists. 2021. 9. Mehrotra DV, Janes HE, Fleming TR, Annunziato PW, Neuzil KM, Carpp LN, et al. Clinical endpoints for evaluating efficacy in COVID-19 vaccine trials. Annals of internal medicine. 2021;174(2):221-8. 10. Wang X. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2021;384(16):1577-8. 11. Alessa MY, Aledili FJ, Alnasser AA, Aldharman SS, Al Dehailan AM, Abuseer HO, et al. The side effects of covid-19 vaccines and their association with abo blood type among general surgeons in Saudi Arabia. Cureus. 2022;14(3). 12. Hatmal MmM, Al-Hatamleh MA, Olaimat AN, Hatmal M, Alhaj-Qasem DM, Olaimat TM, et al. Side effects and perceptions following COVID-19 vaccination in Jordan: a randomized, cross-sectional study implementing machine learning for predicting the severity of side effects. Vaccines. 2021;9(6):556. 13. Aliberti SM, Schiavo L, Boccia G, Santoro E, Franci G, Ruggiero A, et al. Gender and AB0 Blood Type Differences in a Unicentric Group of University Professors in Southern Italy Who Received the Vaxzevria COVID-19 Vaccine: A CrossSectional Survey of Vaccine Side Effects, Attitudes, and Hesitation. Vaccines. 2022;10(3):373. 14. Chew NW, Cheong C, Kong G, Phua K, Ngiam JN, Tan BY, et al. An Asia-Pacific study on healthcare workers’ perceptions of, and willingness to receive, the COVID-19 vaccination. International Journal of Infectious Diseases. 2021;106:52-60. 15. Amit S, Regev-Yochay G, Afek A, Kreiss Y, Leshem E. Early rate reductions of SARS-CoV-2 infection and COVID19 in BNT162b2 vaccine recipients. The Lancet. 2021;397(10277):875-7. 16. El-Shitany NA, Harakeh S, Badr-Eldin SM, Bagher AM, Eid B, Almukadi H, et al. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. International journal of general medicine. 2021:1389-401. 158 Rostami Abusaeedi et al / Archives of Razi Institute, Vol. 79, No. 1 (2024) 149-158 17. Chapin-Bardales J, Gee J, Myers T. Reactogenicity following receipt of mRNA-based COVID-19 vaccines. Jama. 2021;325(21):2201-2. 18. Kashte S, Gulbake A, El-Amin III SF, Gupta A. COVID-19 vaccines: rapid development, implications, challenges, and prospects. Human cell. 2021;34(3):711-33. 19. Nikbakht G. Novel Insights into Infection and Immunity. Iranian Journal of Veterinary Medicine. 2022;16(2):99-100. 20. Van Doremalen N, Lambe T, Spencer A, BelijRammerstorfer S, Purushotham JN, Port JR, et al. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature. 2020;586(7830):578-82. 21. Wang H, Zhang Y, Huang B, Deng W, Quan Y, Wang W, et al. Development of an inactivated vaccine candidate, BBIBPCorV, with potent protection against SARS-CoV-2. Cell. 2020;182(3):713-21. e9. 22. Wise J. Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. British Medical Journal Publishing Group; 2021. 23. Bhattacharjee S, Banerjee M. Immune thrombocytopenia secondary to COVID-19: a systematic review. SN comprehensive clinical medicine. 2020;2:2048-58. 24. Abu-Farha RK, Alzoubi KH, Khabour OF. Public willingness to participate in COVID-19 vaccine clinical trials: a study from Jordan. Patient preference and adherence. 2020:2451-8. 25. Allan JD, McMillan D, Levi ML, McMillan DT. COVID-19 mRNA Vaccination, ABO Blood Type and the Severity of Self-Reported Reactogenicity in a Large Healthcare System: A Brief Report of a Cross-Sectional Study. Cureus. 2021;13(12). 26. Enguita-Germán M, Librero J, Leache L, Gutiérrez-Valencia M, Tamayo I, Jericó C, et al. Role of the AB0 blood group in COVID-19 infection and complications: A population-based study. Transfusion and Apheresis Science. 2022;61(3):103357. | ||
|
آمار تعداد مشاهده مقاله: 11,795 تعداد دریافت فایل اصل مقاله: 224 |
||